Ask whether a medication is approved for your condition, what label-backed dose instructions apply, how side effects are monitored, and what follow-up is needed
Answer: Retatrutide is an investigational once-weekly injectable peptide that activates three hormone receptor systems at once, GLP-1, GIP, and glucagon, to slow digestion, improve insulin response, and directly burn stored fat
In the treatment of type 2 diabetes , it enhances insulin secretion and inhibits glucagon release , effectively controlling blood sugar levels and improving insulin sensitivity
It does not stimulate your pancreas or interact with gut hormones
Side effects of GLP-1 agonists Even though GLP-1 receptor agonists can support weight loss and help you control blood sugar levels, they can also cause side effects